michaelgeist.ca
Did Canada Cave on the Pharmaceutical Patent ISDS Issue in CETA?: Still No Text, But Official Comments Suggests It Did - Michael Geist
For the second time in less than a year, Canada and the EU have announced that they reached agreement on the Canada - EU Trade Agreement. Back in October 2013, there was an announcement of an agreement "in principle". The announcement did not include a release of the text and the parties said there was still further work to be done on drafting and legal analysis. Yesterday, brought another announcement of an agreement on the text. Once again, the announcement did not include a release of the text and the parties said there was still further work to be done on legal review and translation into 23 languages. Given the agreement is 1,500 pages, the additional work is expected to take a considerable amount of time. While government ministers claimed that CETA "is ready for debate and ratification", the reality is that there cannot be a meaningful, informed debate without the actual text. Releasing it for full study and comment is the essential next step. Analysis without the text is difficult, however, the combination of prior leaks and media reports indicate that Canada caved on its concerns regarding the potential replication of Eli Lilly-style pharmaceutical patent lawsuits.
Michael Geist